ClinConnect ClinConnect Logo
Search / Trial NCT03720522

The Bern Heart and Brain Interaction Study - Interaction Between Brain and Heart in Acute Ischemic Stroke

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Oct 23, 2018

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The Bern Heart and Brain Interaction Study is researching how the heart and brain interact during an acute ischemic stroke, which happens when blood flow to the brain is blocked. Understanding the different reasons for this blockage is important because it can help doctors provide better care and reduce the chances of a stroke happening again. The study is currently looking for participants aged 18 to 85 who have experienced a stroke within the last 12 hours and have undergone an MRI that shows signs of this condition.

If you or a family member are considering joining this trial, you will need to provide informed consent, which means you agree to participate after being fully informed about the study. However, pregnant individuals and those with certain medical conditions, like severe kidney failure or specific issues with MRI scans, cannot participate. If eligible, participants can expect to undergo tests and evaluations that will help researchers learn more about the relationship between heart health and stroke recovery. Your involvement could contribute valuable information to improve future treatments for stroke patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Informed consent as documented by signature.
  • Age: ≥ 18 and \< 86 years.
  • Acute ischemic stroke with symptom onset within 12 hours before admission to hospital.
  • Diagnosis of acute ischemic stroke with MRI with diffusion restriction as seen on diffusion weighted imaging.
  • Exclusion Criteria:
  • Pregnancy. A negative pregnancy test upon admission is required for all women with child-bearing potential.
  • Standard contraindication for performing MRI.
  • Severe renal failure (GFR \<40).

About Insel Gruppe Ag, University Hospital Bern

Insel Gruppe AG, the umbrella organization for the University Hospital Bern, is a leading healthcare provider in Switzerland, renowned for its commitment to advancing medical research and patient care. As a key player in clinical trials, Insel Gruppe AG integrates cutting-edge scientific inquiry with clinical excellence, facilitating innovative studies that span a wide range of medical disciplines. The institution prioritizes collaboration with academic partners and industry stakeholders to enhance the understanding of diseases and develop effective treatment options, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Bern, Be, Switzerland

Patients applied

0 patients applied

Trial Officials

Simon Jung, PD Dr. med.

Study Director

Dep. of Neurology, Inselspital Bern

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials